AU2001274088A1 - Screening-method for modulators of methyltransferase-dependent chromosome stability - Google Patents
Screening-method for modulators of methyltransferase-dependent chromosome stabilityInfo
- Publication number
- AU2001274088A1 AU2001274088A1 AU2001274088A AU7408801A AU2001274088A1 AU 2001274088 A1 AU2001274088 A1 AU 2001274088A1 AU 2001274088 A AU2001274088 A AU 2001274088A AU 7408801 A AU7408801 A AU 7408801A AU 2001274088 A1 AU2001274088 A1 AU 2001274088A1
- Authority
- AU
- Australia
- Prior art keywords
- modulators
- suv39h2
- screening
- methyltransferase
- chromosome stability
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 108060004795 Methyltransferase Proteins 0.000 title abstract 2
- 102000016397 Methyltransferase Human genes 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 208000037051 Chromosomal Instability Diseases 0.000 title 1
- 230000001419 dependent effect Effects 0.000 title 1
- 108010077544 Chromatin Proteins 0.000 abstract 1
- 102000011787 Histone Methyltransferases Human genes 0.000 abstract 1
- 108010036115 Histone Methyltransferases Proteins 0.000 abstract 1
- 101000696699 Homo sapiens Histone-lysine N-methyltransferase SUV39H2 Proteins 0.000 abstract 1
- 241001529936 Murinae Species 0.000 abstract 1
- 210000003483 chromatin Anatomy 0.000 abstract 1
- 102000050832 human SUV39H2 Human genes 0.000 abstract 1
- 230000008219 male gametogenesis Effects 0.000 abstract 1
- 238000011275 oncology therapy Methods 0.000 abstract 1
- 229920001184 polypeptide Polymers 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 238000012216 screening Methods 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
- C12N9/1007—Methyltransferases (general) (2.1.1.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91005—Transferases (2.) transferring one-carbon groups (2.1)
- G01N2333/91011—Methyltransferases (general) (2.1.1.)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Analytical Chemistry (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physics & Mathematics (AREA)
- Pharmacology & Pharmacy (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Murine and human Suv39h2 polypeptide and DNA molecules encoding them. <i>Suv39h2</i> is a novel member of the <i>Suv3-9</i> gene family. Suv39h2 is a novel component of meiotic higher order chromatin. It has histone methyltransferase activity and is required, in combination with Suv39h1, for male gametogenesis. Sub39h2 can be used in screening methods to identify modulators of its methyltransferase activity, which are useful in cancer therapy and for male contraception.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP00112479 | 2000-06-09 | ||
| EP00112479A EP1162460A1 (en) | 2000-06-09 | 2000-06-09 | Mammalian Suv39h2 proteins and isolated DNA molecules encoding them |
| EP00112345 | 2000-06-09 | ||
| EP00112345A EP1162274A1 (en) | 2000-06-09 | 2000-06-09 | Method for identifying compounds modifying methyltransferase-dependent chromosome stability |
| PCT/EP2001/006485 WO2001094620A1 (en) | 2000-06-09 | 2001-06-07 | Screening-method for modulators of methyltransferase-dependent chromosome stability |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001274088A1 true AU2001274088A1 (en) | 2001-12-17 |
Family
ID=26071033
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001274088A Abandoned AU2001274088A1 (en) | 2000-06-09 | 2001-06-07 | Screening-method for modulators of methyltransferase-dependent chromosome stability |
| AU2001266055A Abandoned AU2001266055A1 (en) | 2000-06-09 | 2001-06-08 | Screening method for modulators of suv39h2-methyltransferase |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001266055A Abandoned AU2001266055A1 (en) | 2000-06-09 | 2001-06-08 | Screening method for modulators of suv39h2-methyltransferase |
Country Status (7)
| Country | Link |
|---|---|
| EP (2) | EP1294927B1 (en) |
| JP (2) | JP4896344B2 (en) |
| AT (1) | ATE310100T1 (en) |
| AU (2) | AU2001274088A1 (en) |
| DE (1) | DE60115039T2 (en) |
| ES (1) | ES2252240T3 (en) |
| WO (2) | WO2001094620A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2471385A1 (en) * | 2001-12-27 | 2003-07-10 | Takeda Chemical Industries, Ltd. | Preventives/remedies for cancer |
| GB0301450D0 (en) * | 2003-01-22 | 2003-02-19 | Medical Res Council | Protein crystal structure |
| JP3913181B2 (en) * | 2003-02-06 | 2007-05-09 | 三菱重工業株式会社 | Carbon nanofiber manufacturing method and manufacturing apparatus |
| JP5451376B2 (en) * | 2007-03-15 | 2014-03-26 | 株式会社リバース・プロテオミクス研究所 | Biomarkers specific for blood cell lineage or specific for osteoclast differentiation |
| US20140094387A1 (en) * | 2011-06-03 | 2014-04-03 | Oncotherapy Science, Inc. | Suv39h2 as a target gene for cancer therapy and diagnosis |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69836197T2 (en) * | 1997-08-29 | 2007-09-06 | Innogenetics N.V. | METHYLATED SMD HOMOLOGOUS PEPTIDES THAT RESPOND WITH ANTIBODIES FROM SERA OF LIVING WITH SYSTEMIC LUPUS ERYTHEMATODES |
-
2001
- 2001-06-07 DE DE60115039T patent/DE60115039T2/en not_active Expired - Lifetime
- 2001-06-07 AT AT01940552T patent/ATE310100T1/en active
- 2001-06-07 WO PCT/EP2001/006485 patent/WO2001094620A1/en not_active Ceased
- 2001-06-07 EP EP01940552A patent/EP1294927B1/en not_active Expired - Lifetime
- 2001-06-07 ES ES01940552T patent/ES2252240T3/en not_active Expired - Lifetime
- 2001-06-07 AU AU2001274088A patent/AU2001274088A1/en not_active Abandoned
- 2001-06-07 JP JP2002502160A patent/JP4896344B2/en not_active Expired - Lifetime
- 2001-06-08 EP EP01943488A patent/EP1294928A1/en not_active Withdrawn
- 2001-06-08 AU AU2001266055A patent/AU2001266055A1/en not_active Abandoned
- 2001-06-08 JP JP2002502161A patent/JP2003535596A/en active Pending
- 2001-06-08 WO PCT/EP2001/006520 patent/WO2001094621A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001094621A1 (en) | 2001-12-13 |
| WO2001094620A1 (en) | 2001-12-13 |
| ES2252240T3 (en) | 2006-05-16 |
| DE60115039T2 (en) | 2006-07-27 |
| DE60115039D1 (en) | 2005-12-22 |
| JP4896344B2 (en) | 2012-03-14 |
| EP1294928A1 (en) | 2003-03-26 |
| EP1294927A1 (en) | 2003-03-26 |
| JP2003535595A (en) | 2003-12-02 |
| ATE310100T1 (en) | 2005-12-15 |
| AU2001266055A1 (en) | 2001-12-17 |
| EP1294927B1 (en) | 2005-11-16 |
| JP2003535596A (en) | 2003-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU1803601A (en) | Methods and compositions for the introduction of molecules into cells | |
| IL148512A0 (en) | Methods for making recombinant proteins using apoptosis inhibitors | |
| MXPA02007899A (en) | Modified cytokines for use in cancer therapy. | |
| AU2003249227A1 (en) | Methods and systems for extended in vitro culture of neuronal cells | |
| AU2001274088A1 (en) | Screening-method for modulators of methyltransferase-dependent chromosome stability | |
| AU2002230459A1 (en) | Cell culture apparatus and methods of use | |
| AU3522089A (en) | Combination of angiotensin converting enzyme inhibitors with potassium channel modulators and use thereof in pharmaceuticals | |
| AU2002251533A1 (en) | Protein involved in restoration of cytoplasmic male sterility to fertility and gene encoding the protein and gene | |
| WO2001042431A3 (en) | Regulation of human mitochondrial deformylase | |
| AU3028900A (en) | Ras activator nucleic acid molecules, polypeptides and methods of use | |
| AU2002230479A1 (en) | Cell culture apparatus and methods of use | |
| AU9694798A (en) | T cell receptor-associated molecules (trams) and methods of use therefor | |
| BR9407357A (en) | New tripeptides usable in cns and immune therapy | |
| AU2002353146A1 (en) | Cell culture system and methods of use | |
| AU2002360303A1 (en) | Novel histone methyltransferase and methods of its use | |
| AU2002217911A1 (en) | Basal cell carcinoma cultures, methods related thereto and their use | |
| AU1719199A (en) | Two sterile-20 kinase-like proteins and methods of use thereof | |
| AU6430200A (en) | Cyanobacterial strain of the genus nostoc, cultures, biomasses, extracts, bioactive molecules obtained therefrom and use thereof | |
| AU9790398A (en) | Mrit family of cell death proteins, nucleic acids encoding same, and methods of use | |
| WO1994021273A3 (en) | USE OF ANGIOGENINE, AND/OR α1-MICROGLOBULINE AND/OR COMPLEMENTARY FACTOR D FOR LIMITING PROTEIN SECRETION | |
| AU2003251293A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
| AU2003210945A1 (en) | Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof | |
| AU2003222241A1 (en) | Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof | |
| AU2003252219A1 (en) | Novel protein participating in nuclear migaration of substance in nerve cells, gene encoding the protein and utilization of the same | |
| AU6675900A (en) | Replication protein a binding transcriptional factor (rbt1) and uses thereof |